Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02646163
What this trial is testing

Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 8
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Post-approval studies (Phase 4)Looking for participantsNCT04588077
What this trial is testing

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Who this might be right for
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center 200
Not applicableUnknownNCT03589430
What this trial is testing

Haemostatic Imbalance in Patients With Chronic Liver Disease

Who this might be right for
Haemostasis Imbalance in Chronic Liver Disease
Assiut University 100
Not applicableStudy completedNCT01335230
What this trial is testing

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Who this might be right for
HIVHepatitis C, ChronicHCV Coinfection
University of Cincinnati 40
Early research (Phase 1)Study completedNCT01337375
What this trial is testing

The Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 31
Not applicableStudy completedNCT04202081
What this trial is testing

Voices From the Black Community: Hepatitis C Research Participation

Who this might be right for
Hepatitis C, Chronic
University of North Carolina, Chapel Hill 200
Not applicableNot Yet RecruitingNCT07274345
What this trial is testing

Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients

Who this might be right for
Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection
Amira Mohamed Zidan 2,000
Testing effectiveness (Phase 2)Study completedNCT00943761
What this trial is testing

Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Not applicableActive Not RecruitingNCT07316842
What this trial is testing

SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

Who this might be right for
Viral Hepatitis C
Center of target therapy 30
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Not applicableStudy completedNCT01437969
What this trial is testing

Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

Who this might be right for
Liver Disease
Casa Sollievo della Sofferenza IRCCS 500
Not applicableUnknownNCT03887637
What this trial is testing

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 180
Not applicableStudy completedNCT03413696
What this trial is testing

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 150
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Not applicableUnknownNCT02687061
What this trial is testing

Chronic Hepatitis B and C Recall Northern Holland

Who this might be right for
Hepatitis BHepatitis C
Stichting MDL Holland-Noord 300
Not applicableStudy completedNCT02006823
What this trial is testing

Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Duke University 20
Testing effectiveness (Phase 2)Ended earlyNCT00313261
What this trial is testing

Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical
Not applicableStudy completedNCT01577069
What this trial is testing

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

Who this might be right for
Chronic Hepatitis C
Association HGE CHU Bordeaux Sud 73
Next Page